📰 Zai Lab News
Page 67 - Zai Lab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Zai Lab. Real-time updates on events, politics, business and more.
February 16, 2022
/PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business update for the fourth quarter and full...
February 16, 2022
The company expects Ayvakit revenues to more than double in 2022, and projected sales in the range of $115 million to $130 million.
February 3, 2022
Add cancer-focused biotech MacroGenics to the list of biopharmas shoveling out cash for Synaffix's antibody-drug conjugate technology. The Maryland biotech will dish out up to $586 million for access to Synaffix's ADCs for three programs.
January 31, 2022
/PRNewswire/ -- The "Global LAG 3 Inhibitor Clinical Trials & Market Opportunity Insight 2028" report has been added to ResearchAndMarkets.coms offering. The...
January 28, 2022
Research Fellow, Grab-NUS in Computer Science, Academic Posts with NATIONAL UNIVERSITY OF SINGAPORE. Apply Today.
January 25, 2022
/PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced two executive leadership changes highlighting the companys commitment to...
January 20, 2022
Blueprint Medicines Elevates Two Talented Leaders to its Executive Team - read this article along with other careers information, tips and advice on BioSpace
January 20, 2022
GuruFocus Article or News written by PRNewswire and the topic is about:
January 12, 2022
VANCOUVER, BC, Jan. 12, 2022 /PRNewswire/ -- USA News Group - So far in 2022, there have already been some impressive developments in the battle against breast cancer, which over the last
January 12, 2022
/PRNewswire/ -- USA News Group - So far in 2022, there have already been some impressive developments in the battle against breast cancer, which over the last...